Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study
Karolinska Inst, Ctr Alzheimer Res, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, S-14157 Huddinge, Sweden;Karolinska Univ Hosp Huddinge, Theme Aging, S-14186 Stockholm, Sweden.
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Translat Alzheimer Neurobiol, S-14157 Huddinge, Sweden.
Karolinska Univ Hosp Huddinge, Theme Aging, S-14186 Stockholm, Sweden;Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Translat Alzheimer Neurobiol, S-14157 Huddinge, Sweden;Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Clin Geriatr, S-14157 Huddinge, Sweden.
Show others and affiliations
2018 (English)In: Alzheimer's Research & Therapy, ISSN 0065-6755, E-ISSN 1758-9193, Vol. 10, article id 45Article in journal (Refereed) Published
Abstract [en]

Background: The range of onset ages within some PSEN1 families is wide, and a few cases of reduced penetrance of PSEN1 mutations have been reported. However, published data on reduced penetrance have been limited to clinical histories, often collected retrospectively and lacking biomarker information. We present a case of reduced penetrance of the PSEN1 H163Y mutation in a carrier prospectively followed for 22 years.

Methods: Two brothers (A and B), both carriers of the H163Y mutation, were followed between 1995 and 2017. They underwent repeated clinical evaluations, neuropsychological assessments, and cerebrospinal fluid analyses, as well as brain imaging examinations with structural magnetic resonance, [18F]fluorodeoxyglucose positron emission tomography, and [11C]Pittsburgh compound B positron emission tomography.

Results: Brother A was followed between 44 and 64 years of age. Cognitive symptoms due to Alzheimer’s disease set in at the age of 54. Gradual worsening of symptoms resulted in admittance to a nursing home owing to dependence on others for all activities of daily living. He showed a curvilinear decline in cognitive function on neuropsychological tests, and changes on magnetic resonance imaging, positron emission tomography, and biomarkers in the cerebrospinal fluid supported a clinical diagnosis of Alzheimer’s disease. Brother A died at the age of 64 and fulfilled the criteria for definitive Alzheimer’s disease according to neuropathological examination results. Brother B was followed between the ages of 43 and 65 and showed no cognitive deterioration on repeated neuropsychological test occasions. In addition, no biomarker evidence of Alzheimer’s disease pathology was detected, either on imaging examinations or in cerebrospinal fluid.

Conclusions: The average (SD) age of symptom onset for PSEN1 H163Y is 51 ± 7 years according to previous studies. However, we present a case of a biomarker-verified reduction in penetrance in a mutation carrier who was still symptom-free at the age of 65. This suggests that other genetic, epigenetic, and/or environmental factors modify the onset age.

Place, publisher, year, edition, pages
2018. Vol. 10, article id 45
Keywords [en]
Autosomal dominant Alzheimer's disease, CSF, [F-18]fluorodeoxyglucose PET, [C-11]Pittsburgh compound B PET, Reduced penetrance
National Category
Geriatrics
Identifiers
URN: urn:nbn:se:uu:diva-356491DOI: 10.1186/s13195-018-0374-yISI: 000431827700001PubMedID: 29747683OAI: oai:DiVA.org:uu-356491DiVA, id: diva2:1235952
Funder
Swedish Research Council, 05817Swedish Foundation for Strategic Research Knut and Alice Wallenberg FoundationStockholm County CouncilGun och Bertil Stohnes StiftelseStiftelsen Gamla TjänarinnorÅke Wiberg FoundationAvailable from: 2018-07-30 Created: 2018-07-30 Last updated: 2018-07-30Bibliographically approved

Open Access in DiVA

fulltext(1464 kB)1 downloads
File information
File name FULLTEXT01.pdfFile size 1464 kBChecksum SHA-512
1aaf52566842d292a058ae388c822060e29127be423b86e4816575575cc8f6e3a0621347f08ef7f785ba69ae2e35f2171c917b37fe2cca0f4586627dde79714b
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wall, Anders
By organisation
Radiology
In the same journal
Alzheimer's Research & Therapy
Geriatrics

Search outside of DiVA

GoogleGoogle Scholar
Total: 1 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 6 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf